Showing results (1-10 of 131) with videos related to
Sort By:
Pageof 14
In Vivo (Athens, Greece)|November 1, 1993
Serum marker combinations in human breast cancer (review)R Lamerz, P Stieber, A Fateh-MoghadamAnticancer Research|July 1, 1997
Significance of tumor marker determinations in the primary therapy of ovarian cancerW Meier, L Baumgartner, P Stieber, et al.Anticancer Research|July 1, 1997
Prognostic significance of squamous cell carcinoma (SCC) antigen in primary advanced and recurrent cervical carcinomaW Meier, P Stieber, U Hasholzner, et al.Anticancer Research|July 1, 1997
Evaluation of serum neural cell adhesion molecule as a prognostic marker in multiple myelomaS Poley, P Stieber, V Nüssler, et al.Anticancer Research|July 1, 1997
Serum thymidine kinase in non-Hodgkin lymphomas with special regard to multiple myelomaS Poley, P Stieber, V Nüssler, et al.Anticancer Research|March 12, 1998
Alpha 1-antichymotrypsin-PSA (ACT-PSA): a useful marker in the differential diagnosis of benign hyperplasia and cancer of the prostate?W Reiter, P Stieber, N Schmeller, et al.Geburtshilfe Und Frauenheilkunde|September 1, 1992
[Prognostic significance of the CA 125 half-life for the further outcome of ovarian cancer]W Meier, P Stieber, A Fateh-Moghadam, et al.Geburtshilfe Und Frauenheilkunde|July 1, 1989
[Experiences with the squamous cell carcinoma antigen, a new tumor marker for cancer of the uterine cervix]W Meier, W Eiermann, P Stieber, et al.Geburtshilfe Und Frauenheilkunde|December 1, 1989
[The course of squamous cell carcinoma antigen and CEA as prognostic criteria for response to chemotherapy in cervix cancer]W Meier, W Eiermann, P Stieber, et al.Geburtshilfe Und Frauenheilkunde|May 1, 1988
[Serum CA 125 values and histologic findings at the time of second-look laparotomy in ovarian cancer]W Meier, P Stieber, A Fateh-Moghadam, et al.Pageof 14